Pharmacological evidence for different populations of postsynaptic adenosine A 2A receptors in the rat striatum

Neuropharmacology

Volumn 61, Issue 5-6, 2011, Pages 967-974

  Orrú, Marco ^a   Quiroz, César ^a   Guitart, Xavier ^a   Ferré, Sergi ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Adenosine A 2A receptor; Cannabinoid CB 1 receptor; Dopamine D 2 receptor; Glutamate; Locomotor activity; Microdialysis; Striatum

Indexed keywords

5 AMINO 2 (2 FURYL) 7 [3 (4 METHOXYPHENYL)PROPYL]PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR ANTAGONIST; CANNABINOID 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLUTAMIC ACID; RACLOPRIDE TARTRATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM DEPRESSION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG POTENTIATION; DRUG TARGETING; ELECTROSTIMULATION; MALE; MOTOR DEPRESSION; MOTOR PERFORMANCE; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT;

ADENOSINE A2 RECEPTOR AGONISTS; ADENOSINE A2 RECEPTOR ANTAGONISTS; ANIMALS; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; DRUG EVALUATION, PRECLINICAL; ELECTRIC STIMULATION; GLUTAMIC ACID; MALE; MOLECULAR TARGETED THERAPY; MOTOR ACTIVITY; NEOSTRIATUM; PIPERIDINES; PYRAZOLES; PYRIMIDINES; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL; XANTHINES;

EID: 80051793442     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.06.025     Document Type: Article

References (32)

1. M. Andersson, A. Usiello, A. Borgkvist, L. Pozzi, C. Dominguez, A.A. Fienberg, P. Svenningsson, B.B. Fredholm, E. Borrelli, P. Greengard, and G. Fisone Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons J. Neurosci. 25 2005 8432 8438 (Pubitemid 41324729)
2. K. Azdad, D. Gall, A.S. Woods, C. Ledent, S. Ferré, and S.N. Schiffmann Dopamine D2 and adenosine A2A receptors regulate NMDA-excitation in accumbens neurons through A2A-D2 receptor heteromerization Neuropsychopharmacology 34 2009 972 986
3. J. Bertran-Gonzalez, K. Hkansson, A. Borgkvist, T. Irinopoulou, K. Brami-Cherrier, A. Usiello, P. Greengard, D. Hervé, J.A. Girault, E. Valjent, and G. Fisone Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons Neuropsychopharmacology 34 2009 1710 1720
4. 1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids Neuropsychopharmacology 32 2007 2249 2259 (Pubitemid 47587686)
5. J.F. Chen, R. Moratalla, F. Impagnatiello, D.K. Grandy, B. Cuellar, M. Rubinstein, M.A. Beilstein, E. Hackett, J.S. Fink, M.J. Low, E. Ongini, and M.A. Schwarzschild The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice Proc. Natl. Acad. Sci. U.S.A. 98 2001 1970 1975 (Pubitemid 32165607)
6. F. Ciruela, V. Casado, R.J. Rodrigues, R. Luján, J. Burgueno, M. Canals, J. Borycz, N. Rebola, S.R. Goldberg, J. Mallol, A. Cortés, E.I. Canela, J.F. López-Giménez, G. Milligan, C. Lluis, R.A. Cunha, S. Ferré, and R. Franco Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers J. Neurosci. 26 2006 2080 2087
7. M.R. DeLong, and T. Wichmann Circuits and circuit disorders of the basal ganglia Arch. Neurol. 64 2007 20 24 (Pubitemid 46072419)
8. S. Ferré, C. Quiroz, A.S. Woods, R. Cunha, P. Popoli, F. Ciruela, C. Lluis, R. Franco, K. Azdad, and S.N. Schiffmann An update on adenosine A2A-dopamine D2 receptor interactions. Implications for the function of G protein-coupled receptors Curr. Pharm. Des. 14 2008 1468 1474 (Pubitemid 351997812)
9. S. Ferré, C. Lluis, Z. Justinova, C. Quiroz, M. Orru, G. Navarro, E.I. Canela, R. Franco, and S.R. Goldberg Adenosine-cannabinoid receptor interactions. Implications for striatal function Br. J. Pharmacol. 160 2010 443 453
10. K. Hkansson, S. Galdi, J. Hendrick, G. Snyder, P. Greengard, and G. Fisone Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors J. Neurochem. 96 2006 482 488
11. M.J. Higley, and B.L. Sabatini Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors Nat. Neurosci. 13 2010 958 966
12. 2 receptors J. Biol. Chem. 277 2002 18091 18097 (Pubitemid 34967623)
13. J. Hockemeyer, J.C. Burbiel, and C.E. Müller Multigram-scale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinson's disease J. Org. Chem. 69 2004 3308 3318 (Pubitemid 38621277)
14. Z. Justinova, S. Ferré, G.H. Redhi, P. Mascia, J. Stroik, D. Quarta, S. Yasar, C.E. Muller, R. Franco, and S.R. Goldberg Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist Addict. Biol. 2010 10.1111/j.1369-1600.2010.00258.x
15. M. Karcz-Kubicha, D. Quarta, B.T. Hope, K. Antoniou, C.E. Müller, M. Morales, C.W. Schindler, S.R. Goldberg, and S. Ferré Enabling role of adenosine A1 receptors in adenosine A2A receptor-mediated striatal expression of c-fos Eur. J. Neurosci. 18 2003 296 302
16. M. Karcz-Kubicha, K. Antoniou, A. Terasmaa, D. Quarta, M. Solinas, Z. Justinova, A. Pezzola, R. Reggio, C.E. Müller, K. Fuxe, S.R. Goldberg, P. Popoli, and S. Ferré Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration Neuropsychopharmacology 28 2003 1281 1291 (Pubitemid 41070898)
17. 2 receptors in CHO cells co-transfected with the two receptors Biochem. Pharmacol. 58 1999 1035 1045 (Pubitemid 29361470)
18. A.C. Kreitzer, and R.C. Malenka Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models Nature 445 2007 643 647 (Pubitemid 46232883)
19. T.N. Lerner, E.A. Horne, N. Stella, and A.C. Kreitzer Endocannabinoid signaling mediates psychomotor activation by adenosine A2A antagonists J. Neurosci. 30 2010 2160 2164
20. M. Marti, M. Manzalini, M. Fantin, C. Bianchi, L. Della Corte, and M. Morari Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine J. Neurochem. 93 2005 195 205 (Pubitemid 40463529)
21. A. Martire, M.T. Tebano, V. Chiodi, S.G. Ferreira, R.A. Cunha, A. Köfalvi, and P. Popoli Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission J. Neurochem. 116 2011 273 280
22. M. Orrú, J. Bakešová, M. Brugarolas, C. Quiroz, V. Beaumont, S.R. Goldberg, C. Lluís, A. Cortés, R. Franco, V. Casadó, E.I. Canela, and S. Ferré Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonists PLoS One 6 2011 e16088
23. 2A receptors in cortical neurotransmission to the striatal direct pathway Sci. World J. 9 2009 1321 1344
24. D.L. Rosin, B.D. Hettinger, A. Lee, and J. Linden Anatomy of adenosine A2A receptors in brain: morphological substrates for integration of striatal function Neurology 61 2003 S12 S18
25. S.N. Schiffmann, G. Fisone, R. Moresco, R. Cunha, and S. Ferré Adenosine A2A receptors and basal ganglia physiology Prog. Neurobiol. 83 2007 277 292 (Pubitemid 350110609)
26. M. Solinas, G. Tanda, C.E. Wertheim, and S.R. Goldberg Dopaminergic augmentation of delta-9-tetrahydrocannabinol (THC) discrimination: possible involvement of D(2)-induced formation of anandamide Psychopharmacology 209 2010 191 202
27. G. Soria, A. Castañé, C. Ledent, M. Parmentier, R. Maldonado, and O. Valverde Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC Eur. J. Neurosci. 20 2004 2203 2213 (Pubitemid 39331141)
28. P. Svenningsson, L. Fourreau, B. Bloch, B.B. Fredholm, F. Gonon, and C. Le Moine Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons Neuroscience 89 1999 827 837 (Pubitemid 29071007)
29. M.T. Tebano, A. Martire, V. Chiodi, R. Pepponi, A. Ferrante, M.R. Domenici, C. Frank, J.F. Chen, C. Ledent, and P. Popoli Adenosine A2A receptors enable the synaptic effects of cannabinoid CB1 receptors in the rodent striatum J. Neurochem. 110 2009 1921 1930
30. A. Tozzi, A. de Iure, M. Di Filippo, M. Tantucci, C. Costa, F. Borsini, V. Ghiglieri, C. Giamp, F.R. Fusco, B. Picconi, and P. Calabresi The distinct role of medium spiny neurons and cholinergic interneurons in the D2/A2A receptor interaction in the striatum: implications for Parkinson's disease J. Neurosci. 31 2011 1850 1862
31. L. Yao, P. Fan, Z. Jiang, W.S. Mailliard, A.S. Gordon, and I. Diamond Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-beta gamma dimers Proc. Natl. Acad. Sci. U.S.A. 100 2003 14379 14384 (Pubitemid 37499245)
32. Z.B. You, Y.Q. Chen, and R.A. Wise Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation Neuroscience 107 2001 629 639 (Pubitemid 33097499)